Effect of Sodium-Glucose Cotransporter 2 Inhibitors on the 24-Hour Ambulatory Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension: An Updated Meta-Analysis-Reference-Cited by-同舟云学术

Effect of Sodium-Glucose Cotransporter 2 Inhibitors on the 24-Hour Ambulatory Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension: An Updated Meta-Analysis

Published:2024-05 Issue:5 Volume:30 Page:481-489
ISSN:1530-891X
Container-title:Endocrine Practice
language:en
Short-container-title:Endocrine Practice

Author:

Iqbal Fizza^ORCID,Shuja Muhammad Hamza,Azam Laraib,Amjad Marium,Manjee Kashish Zehra,Ramzan Hurriyah,Sharif Taha,Shoaib Ayesha,Tahir Amber,Kumar Satesh,Khatri Mahima,Varrassi Giustino,Mohamad Tamam

Publisher

Elsevier BV

Reference41 articles.

1. Standards of care in diabetes-2023 abridged for primary care providers;Clin Diabetes,2022

2. Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study;Fox;Diabetes Care,2008

3. Prevalence of hypertension in type 2 diabetes mellitus: impact of the tightening definition of high blood pressure and association with confounding risk factors;Kabakov;J Cardiometab Syndr,2006

4. Diabetes and hypertension: the bad companions;Ferrannini;Lancet,2012

5. Pharmacokinetic and pharmacodynamic profile of empagliflozin, a sodium glucose co-transporter 2 inhibitor;Scheen;Clin Pharmacokinet,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium-glucose cotransporter 2 inhibitors and renin-angiotensin-aldosterone system, possible cellular interactions and benefits;Cellular Signalling;2024-10

2. The drug called food and its role as a therapy for chronic patients: a comprehensive narrative review;Advancements in Health Research;2024-05-07